Victoria Chatzimavridou Grigoriadou (Victoria Chatzimavridou-Grigoriadou)

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Victoria Chatzimavridou Grigoriadou, Lisa H Barraclough, Ivona Baricevic-Jones, Robert G Bristow, Martin Eden, Kate Haslett, Karen Johnson, Rohit Kochhar, Zoe Merchant, John Moore, Sarah O'Connell, Sally Taylor, Thomas Westwood, Anthony David Whetton, Janelle Yorke, Claire E Higham
RadBone: bone toxicity following pelvic radiotherapy - a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy. BMJ open 12 (6) (2022)
Victoria Chatzimavridou Grigoriadou, Sami Al-Othman, Georg Brabant, Angelos Kyriacou, Jennifer King, Fiona Blackhall, Peter J Trainer, Claire E Higham
Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting. The Journal of clinical endocrinology and metabolism 106 (11) (2021)

Victoria Chatzimavridou Grigoriadou.css-eqlu8i{font-size:small;padding-left:4px;} (Victoria Chatzimavridou-Grigoriadou)